• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Premier Inc.

    9/22/25 9:20:28 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary
    Get the next $PINC alert in real time by email
    8-K
    false 0001577916 0001577916 2025-09-21 2025-09-21
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (date of earliest event reported): September 21, 2025

     

     

    Premier, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-36092   35-2477140

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

    13520 Ballantyne Corporate Place

    Charlotte, NC 28277

    (Address of principal executive offices)

    Registrant’s telephone number, including area code: (704) 357-0022

    N/A

    (Former name or former address, if changed since last report.)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☒

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Class A Common Stock, par value $0.01 per share   PINC   NASDAQ Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 1.01

    Entry into a Material Definitive Agreement.

    Agreement and Plan of Merger

    On September 21, 2025, Premier, Inc. (“Premier” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Premium Parent, LLC, a Delaware limited liability corporation (“Parent”), and Premium Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”).

    The Merger Agreement provides that, among other things and on the terms and subject to the conditions of the Merger Agreement, (i) Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent (the “Surviving Corporation”); (ii) at the effective time of the Merger (the “Effective Time”), each issued and outstanding share of Class A common stock of the Company, par value $0.01 per share (the “Company Class A Common Stock”) (the “Shares”), other than (a) shares of Company Class A Common Stock that, immediately prior to the Effective Time, are held by the Company or any of its subsidiaries and not held on behalf of third parties, (b) shares of Company Class A Common Stock that are owned by Parent or Merger Sub, in each case immediately prior to the Effective Time, and (c) shares of Company Class A Common Stock that are issued and outstanding immediately prior to the Effective Time and that are held by any holder who is entitled to demand and properly demands appraisal of such shares of Company Class A Common Stock pursuant to Section 262 of the General Corporation Law of the State of Delaware, will be automatically converted into the right to receive $28.25 per Share in cash, without interest (the “Merger Consideration”).

    The Board of Directors of the Company (the “Board”) has unanimously (i) determined that the terms of the Merger Agreement and the transactions contemplated thereby, including the Merger, are fair to, and in the best interests of, the Company and its stockholders, that it is in the best interests of the Company and its stockholders and advisable to enter into the Merger Agreement, approved the execution and delivery by the Company of the Merger Agreement, the performance by the Company of its covenants and agreements contained therein and the consummation of the Merger and any other transaction contemplated thereby upon the terms and subject to the conditions contained therein, (ii) resolved to recommend that the Company’s stockholders vote to approve the Merger Agreement, in each case on the terms and subject to the conditions set forth in the Merger Agreement and (iii) directed that the Merger Agreement be submitted to the Company’s stockholders for their adoption.

    If the Merger is consummated, the Company Class A Common Stock will be delisted from the NASDAQ Global Select Market and deregistered under the Securities Exchange Act of 1934, as amended.

    Treatment of Company Equity Awards

    As of the Effective Time, the Merger Agreement provides for the following treatment of outstanding Company equity awards:

    Options

    Each outstanding option to purchase Shares, whether or not vested, will be cancelled for no consideration.

    RSU Awards

     

      •  

    Subject to limited exceptions, each outstanding restricted stock unit award corresponding to Shares (a “Company RSU Award”) granted before August 16, 2025, whether or not vested, shall be cancelled and converted into the right to receive an amount in cash (without interest) equal to (a) the number of Shares subject to such Company RSU Award multiplied by (b) the Merger Consideration.

     

      •  

    Each Company RSU Award granted on or after August 16, 2025 shall be cancelled for no consideration.

    PSU Awards

     

      •  

    Each outstanding performance share award corresponding to Shares (a “Company PSU Award”) granted before August 16, 2025, whether or not vested, shall be cancelled and converted into the right to receive an


     

    amount in cash (without interest) equal to (a) the number of Shares subject to such Company PSU Award multiplied by (b) the Merger Consideration. The number of Shares underlying a Company PSU Award shall be equal to: (i) in the case of Company PSU Awards covering the fiscal year 2024 through 2026 performance period, 68.75% of the target number of Shares covered by such Company PSU Award for all individuals other than Company named executive officers as defined in Item 402 of Regulation S-K promulgated under the Securities Act of 1933, as amended, and 0% of the target number of Shares covered by such Company PSU Award for the Company’s named executive officers, and (ii) in the case of Company PSU Awards covering the fiscal year 2025 through 2027 performance period, 105.17% of the target number of Shares covered by such Company PSU Award.

     

      •  

    Each Company PSU Award granted on or after August 16, 2025 shall be cancelled for no consideration.

    Conditions to the Merger

    The completion of the Merger is subject to the fulfillment or waiver of certain customary mutual closing conditions, including, (i) the adoption of the Merger Agreement by holders of a majority of the aggregate voting power of the outstanding shares of Company Class A Common Stock entitled to vote thereon, voting together as a single class, (ii) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and (iii) the absence of any law or order by a governmental authority enjoining or otherwise prohibiting consummation of the Merger. The obligation of each party to consummate the Merger is also conditioned upon certain unilateral closing conditions, including the other party’s representations and warranties being accurate (subject to certain customary materiality exceptions) and the other party having performed in all material respects its obligations under the Merger Agreement. The obligation of Parent and Merger Sub to consummate the Merger is also conditioned upon there being no continuing Material Adverse Effect (as defined in the Merger Agreement). The consummation of the Merger is not subject to any financing condition.

    Termination and Fees

    The Merger Agreement contains termination rights for each of Parent and the Company, including, among others, (i) if the consummation of the Merger does not occur on or before March 21, 2026 (the “Outside Date”), subject to one three-month extension if on such date all of the closing conditions in the Merger Agreement have been satisfied or waived, except for those relating to regulatory approvals and those conditions that by their nature are to be satisfied at the closing but provided that such conditions are capable of being satisfied if the closing were to take place on such date), (ii) if any court or governmental authority shall have enacted, issued, promulgated or entered any final and non-appealable order that permanently enjoins or otherwise permanently prohibits the consummation of the Merger, (iii) if the approval of the Company’s stockholders is not obtained following the meeting of the Company’s stockholders for purposes of obtaining such approval, (iv) by the Company if Parent or Merger Sub (in the case of termination by the Company) or Parent if the Company (in the case of termination by Parent) breaches or fails to perform their covenants or if any of their representations or warranties are untrue, such that the conditions to closing for the terminating party fail to be satisfied (subject to a cure period) (“uncured breach”) or (iv) subject to certain conditions, (a) by Parent, if the Board makes an adverse recommendation change with respect to the Merger or (b) by the Company, if (1) the Company wishes to terminate the Merger Agreement to enter into a definitive contract with respect to a Superior Proposal (as defined by the Merger Agreement) or (2) if Parent and Merger Sub fail to effect the closing on or prior to the date that is three business days after the closing would have occurred pursuant to the Merger agreement, and after the closing conditions have been satisfied (other than those conditions that by their nature are to be satisfied at the closing, but which are capable of being satisfied at the closing) and the Company stands ready, willing and able to consummate the transaction (“Parent’s Failure to Close”).

    The Company will be required to pay a termination fee to Parent equal to approximately $66,215,100 if the Merger Agreement is terminated in certain specified circumstances, including the termination by Parent in the event of a change of recommendation by the Board or the termination by the Company to enter into a contract with respect to a Superior Proposal.

    Parent will be required to pay a termination fee to the Company equal to approximately $168,550,000 (the “Parent score Termination Fee”) if the Company terminates the Merger Agreement due to Parent’s and Merger Sub’s uncured breach or Parent’s Failure to Close (or Parent terminates following the Outside Date, where the Company could have validly terminated pursuant to the foregoing).

     


    Financing

    Parent has obtained equity financing commitments for the purpose of financing the transactions contemplated by the Merger Agreement and paying related fees and expenses. In addition, certain affiliates of Parent have guaranteed payment of the Parent Termination Fee, the monetary damages payable by Parent under certain circumstances, as well as certain reimbursement and indemnification obligations that may be owed by Parent, in each case, pursuant to the Merger Agreement. The consummation of the Merger is not subject to any financing condition.

    Parent has obtained commitments for debt financing consisting of a $1,450 million senior secured first lien term loan facility and a $225 million senior secured revolving credit facility on the terms set forth in a debt commitment letter. The obligations of the lenders to provide debt financing under the debt commitment letter are subject to customary conditions. Pursuant to the Merger Agreement, the Company is required to use reasonable best efforts to provide Parent with customary cooperation in connection with the debt financing.

    Other Terms of the Merger Agreement

    The Company has made customary representations, warranties and covenants in the Merger Agreement, including, among others, covenants to use commercially reasonable efforts to conduct its business in the ordinary course during the period between the date of the Merger Agreement and the closing. The parties have agreed to use reasonable best efforts to take all actions necessary, proper or advisable under applicable laws to consummate the Merger, including cooperating to obtain the regulatory approvals necessary to complete the Merger.

    The Merger Agreement provides that, during the period from the date of the Merger Agreement until the earlier of the termination of the Merger Agreement and the Effective Time, the Company will be subject to certain restrictions on its ability to solicit alternative acquisition proposals from third parties, to provide non-public information to third parties and to engage in discussions with third parties regarding alternative acquisition proposals, subject to customary exceptions. Unless the Merger Agreement is terminated in accordance with its terms, the Company is required to call a meeting of its stockholders to vote upon the adoption of the Merger Agreement and, subject to certain exceptions, to recommend that its stockholders vote to adopt the Merger Agreement.

    The foregoing description of the Merger Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Merger Agreement, a copy of which is filed as Exhibit 2.1 hereto and is incorporated by reference herein.

    The Merger Agreement has been included to provide investors with information regarding its terms. It is not intended to provide any other factual information about the Company, Parent, Merger Sub or their respective affiliates. The representations, warranties and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement as of the specific dates therein, were solely for the benefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk among the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be reflected in the Company’s public disclosures. The Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Company, Parent and Merger Sub and the transactions contemplated by the Merger Agreement that will be contained in or attached as an annex to the Proxy Statement that the Company will file in connection with the transaction contemplated by the Merger Agreement, as well as in the other filings that the Company will make with the U.S. Securities and Exchange Commission (the “SEC”).


    Item 8.01

    Other Events.

    On September 22, 2025, the Company issued a press release announcing entry into the Merger Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

    Additional Information and Where to Find It

    In connection with the Merger, the Company will file relevant materials with the SEC, including the Company’s proxy statement on Schedule 14A (the “Proxy Statement”). This communication is not a substitute for the Proxy Statement or for any other document that the Company may file with the SEC and send to its stockholders in connection with the Merger. The Merger will be submitted to the Company’s stockholders for their consideration. BEFORE MAKING ANY VOTING DECISION, THE COMPANY’S STOCKHOLDERS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE MERGER.

    The Company’s stockholders will be able to obtain a free copy of the Proxy Statement, as well as other filings containing information about the Company, without charge, at the SEC’s website (www.sec.gov). Copies of the Proxy Statement and the filings with the SEC that will be incorporated by reference therein can also be obtained, without charge, by directing a request to Premier Inc., 13520 Ballantyne Corporate Place, Charlotte, North Carolina, 28277, or from the Company’s website, www.premierinc.com.

    Participants in the Solicitation

    The Company and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the Merger. Information regarding the Company’s directors and executive officers is available in the Company’s proxy statement for the 2024 annual meeting of stockholders, which was filed with the SEC on October 21, 2024 (the “2024 Annual Meeting Proxy Statement”), and in other documents filed by the Company with the SEC. Please refer to, among other things, the sections captioned “Compensation of Directors,” “Compensation Discussion and Analysis” and “Security Ownership of Certain Beneficial Owners and Management” in the 2024 Annual Meeting Proxy Statement. To the extent holdings of such participants in the Company’s securities have changed since the amounts described in the 2024 Annual Meeting Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC: Form 3 filed by Glenn Coleman on November 12, 2024; Form 3 filed by David P. Zito on December 9, 2024; Forms 4, filed by Glenn Coleman on November 12, 2024, August 20, 2025 and August 22, 2025; Forms 4, filed by Michael J. Alkire on November 14, 2024, December 12, 2024, August 20, 2025, August 22, 2025 and August 26, 2025; Forms 4, filed by John T. Bigalke on December 6, 2024, December 10, 2024, March 6, 2025, June 5, 2025 and September 4, 2025; Forms 4, filed by David P. Zito on December 9, 2024, August 20, 2025 and August 22, 2025; Form 4, filed by Ellen C. Wolf on December 10, 2024; Form 4, filed by Richard J. Statuto on December 10, 2024; Form 4, filed by Marvin R. O’Quinn on December 10, 2024; Form 4, filed by Peter Fine on December 10, 2024; Form 4, filed by Jody R. Davids on December 10, 2024; Forms 4, filed by Helen M. Boudreau on December 10, 2024, January 7, 2025 and June 2, 2025; Form 4, filed by Marc D. Miller on December 10, 2024; Form 4, filed by Leigh Anderson on December 23, 2024; Forms 4, filed by David L. Klatsky on April 3, 2025, May 7, 2025, August 20, 2025, August 22, 2025, August 26, 2025 and August 27, 2025; Forms 4, filed by Andy Brailo on May 7, 2025, August 20, 2025, August 22, 2025, August 26, 2025, September 4, 2025, and September 8, 2025; Forms 4 filed by Crystal Climer on August 20, 2025, August 22, 2025 and August 26, 2025. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement and other relevant materials to be filed with the SEC in connection with the Merger when they become available. Free copies of the Proxy Statement and such other materials may be obtained as described in the preceding paragraph.


    Forward-Looking Statements

    This communication includes forward-looking statements within the meaning of the “safe harbor” provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on a number of assumptions about future events and are subject to various known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from historical results or from any future results, projections, views, beliefs and estimates expressed or implied by such forward-looking statements. These risks, uncertainties and other factors include, but are not limited to, those discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (the “Annual Report”), Current Reports on Form 8-K and other documents filed with the SEC, including documents that will be filed with the SEC in connection with the Merger, and the following: (1) the inability to consummate the Merger within the anticipated time period, or at all, due to any reason, including the failure to obtain required regulatory approvals, satisfy the other conditions to the consummation of the Merger (including the failure to obtain necessary regulatory approvals or the approval of the Company’s stockholders) or complete contemplated financing arrangements, (2) the risk that any announcements relating to the Merger could have adverse effects on the market price of the Company Class A Common Stock, (3) disruption from the Merger making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel and maintaining relationships with the Company’s customers, vendors and others with whom it does business, (4) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into in connection with the Merger, (5) risks related to disruption of the Company’s current plans and operations or the diversion of management’s attention from the Company’s ongoing business operations due to the Merger, (6) significant transaction costs and (7) the risk of litigation and/or regulatory actions related to the Merger or unfavorable results from currently pending litigation and proceedings or litigation and proceedings that could arise in the future. The foregoing list of important factors is not exhaustive. Readers are cautioned not to place undue reliance on forward-looking statements made by or on behalf of the Company. Each such statement speaks only as of the day it was made. The Company undertakes no obligation to update or to revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Furthermore, the Company cannot guarantee future results, events, levels of activity, performance, or achievements. The factors described above cannot be controlled by the Company. When used in this communication, the words “believes,” “estimates,” “plans,” “expects,” “should,” “could,” “outlook,” “anticipates” and similar expressions as they relate to the Company or its management are intended to identify forward-looking statements. Forward-looking statements in this communication may include, without limitation: statements about the potential benefits of the Merger, anticipated growth rates, the Company’s plans, objectives, expectations, and the anticipated timing of closing the Merger.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit No.

      

    Description

    2.1    Agreement and Plan of Merger, by and among Premium Parent, LLC, Premium Merger Sub, Inc. and Premier, Inc., dated as of September 21, 2025. †
    99.1    Press Release, dated September 22, 2025.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    †

    Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: September 22, 2025     PREMIER, INC.
        By:  

    /s/ Michael J. Alkire

          Name: Michael J. Alkire
          Title:  President and Chief Executive Officer
    Get the next $PINC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PINC

    DatePrice TargetRatingAnalyst
    8/26/2024Buy → Hold
    The Benchmark Company
    5/8/2024$27.00 → $21.00Buy → Hold
    Canaccord Genuity
    2/26/2024$22.50Market Perform
    Leerink Partners
    1/3/2024$22.00Equal Weight
    Barclays
    8/23/2023$44.00 → $25.00Overweight → Neutral
    Piper Sandler
    5/3/2023$43.00 → $30.00Outperform → Neutral
    Robert W. Baird
    5/2/2023Outperform → Mkt Perform
    Raymond James
    1/27/2023$38.00Underperform → Neutral
    Credit Suisse
    More analyst ratings

    $PINC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Premier, Inc. Announces Definitive Agreement to Be Acquired by Patient Square Capital in Transaction Valued at $2.6 Billion

    Stockholders to Receive $28.25 Per Share in Cash Premier, Inc. (NASDAQ:PINC) ("Premier" or the "Company"), a leading technology-driven health care improvement company, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital ("Patient Square"). Under the terms of the agreement, which has been unanimously approved by Premier's Board of Directors, Premier stockholders will receive $28.25 in cash per share, representing a 23.8% premium to Premier's 60-day volume-weighted average price as of September 5, 2025.1 "We are pleased to have reached this agreement and delighted that Patient Square recognizes and is committed to enha

    9/22/25 6:30:00 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Premier Infusion and Healthcare Services, Inc. (Premier Infusion and HCS) Selects Premier, Inc. as Its GPO Partner to Power Ambulatory Infusion Growth

    The five-year agreement supports Premier Infusion and HCS's continued growth in the outpatient infusion market. Premier Infusion and HCS's access to Premier, Inc.'s comprehensive group purchasing services will support an estimated annual contract spend of more than $50 million. This collaboration underscores Premier, Inc.'s commitment to improving healthcare access and operational efficiency for Continuum of Care providers nationwide. Premier, Inc. (NASDAQ:PINC), a leading technology-enabled healthcare performance improvement company, today announced that it has entered a five-year group purchasing agreement with Premier Infusion and Healthcare Services, Inc. (Premier Infusion and

    9/16/25 2:49:00 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Premier, Inc. Appoints Bruce Radcliff as President of Supply Chain Services

    Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that it has named Bruce Radcliff as President of Supply Chain Services, effective September 1. In this role, Radcliff oversees Premier's core supply chain business including sourcing, contract management, operations and business analytics. Radcliff is a seasoned executive with more than 15 years of experience within large healthcare providers and over a decade of supply chain leadership. He joined Premier in May 2023 as Group Vice President of Strategic Sourcing and has helped enhance the competitiveness and differentiation of the company's group purchasing business by bringing a stron

    9/9/25 1:20:00 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    $PINC
    SEC Filings

    View All

    SEC Form PREM14A filed by Premier Inc.

    PREM14A - Premier, Inc. (0001577916) (Filer)

    10/8/25 5:24:27 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    SEC Form DEFA14A filed by Premier Inc.

    DEFA14A - Premier, Inc. (0001577916) (Filer)

    9/22/25 5:20:57 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    SEC Form DEFA14A filed by Premier Inc.

    DEFA14A - Premier, Inc. (0001577916) (Filer)

    9/22/25 5:19:53 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    $PINC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Radcliff Bruce J. claimed ownership of 31,156 shares (SEC Form 3)

    3 - Premier, Inc. (0001577916) (Issuer)

    10/1/25 4:25:27 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Chief Commercial Officer Brailo Andy sold $146,724 worth of shares (5,581 units at $26.29), decreasing direct ownership by 6% to 93,866 units (SEC Form 4)

    4 - Premier, Inc. (0001577916) (Issuer)

    9/8/25 2:35:43 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Chief Commercial Officer Brailo Andy sold $168,177 worth of shares (6,521 units at $25.79), decreasing direct ownership by 6% to 99,447 units (SEC Form 4)

    4 - Premier, Inc. (0001577916) (Issuer)

    9/4/25 4:57:59 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    $PINC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Premier downgraded by The Benchmark Company

    The Benchmark Company downgraded Premier from Buy to Hold

    8/26/24 7:41:33 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Premier downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Premier from Buy to Hold and set a new price target of $21.00 from $27.00 previously

    5/8/24 6:31:59 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Leerink Partners initiated coverage on Premier with a new price target

    Leerink Partners initiated coverage of Premier with a rating of Market Perform and set a new price target of $22.50

    2/26/24 8:19:13 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    $PINC
    Financials

    Live finance-specific insights

    View All

    Premier, Inc. Announces Definitive Agreement to Be Acquired by Patient Square Capital in Transaction Valued at $2.6 Billion

    Stockholders to Receive $28.25 Per Share in Cash Premier, Inc. (NASDAQ:PINC) ("Premier" or the "Company"), a leading technology-driven health care improvement company, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital ("Patient Square"). Under the terms of the agreement, which has been unanimously approved by Premier's Board of Directors, Premier stockholders will receive $28.25 in cash per share, representing a 23.8% premium to Premier's 60-day volume-weighted average price as of September 5, 2025.1 "We are pleased to have reached this agreement and delighted that Patient Square recognizes and is committed to enha

    9/22/25 6:30:00 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results

    Fourth-quarter total net revenue of $262.9 million was better than the company expected (total net revenue excluding Contigo Health* of $258.0 million) Fourth-quarter GAAP net income from continuing operations of $18.0 million, or $0.22 per fully diluted share Fourth-quarter adjusted EPS of $0.46, excluding Contigo Health* contributed to full-year adjusted EPS that was above the high end of the company's guidance range Full-year net cash provided by operating activities from continuing operations of $417.8 million and free cash flow* of $180.5 million; both were better than the company anticipated Providing fiscal-year 2026 financial guidance Premier, Inc. (NASDAQ:PINC), a l

    8/19/25 6:30:00 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Premier, Inc. Declares Quarterly Cash Dividend

    Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2025, to stockholders of record as of the close of business on September 1, 2025. About Premier, Inc. Premier, Inc. (NASDAQ:PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with natio

    8/18/25 8:30:00 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    $PINC
    Leadership Updates

    Live Leadership Updates

    View All

    Premier, Inc. Appoints Bruce Radcliff as President of Supply Chain Services

    Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that it has named Bruce Radcliff as President of Supply Chain Services, effective September 1. In this role, Radcliff oversees Premier's core supply chain business including sourcing, contract management, operations and business analytics. Radcliff is a seasoned executive with more than 15 years of experience within large healthcare providers and over a decade of supply chain leadership. He joined Premier in May 2023 as Group Vice President of Strategic Sourcing and has helped enhance the competitiveness and differentiation of the company's group purchasing business by bringing a stron

    9/9/25 1:20:00 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    Premier, Inc. Appoints David Zito as President, Performance Services

    Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that it has named David (Dave) Zito as President, Performance Services, effective December 6, 2024. Zito will oversee Premier's Performance Services segment, including the continued development and growth of the company's enterprise-wide, AI-enabled technology businesses and Premier's consulting practice. He will report to Michael J. Alkire, Premier's President and CEO. Zito is a seasoned healthcare executive, with expertise across provider networks, payer systems, life sciences and healthcare managed services. He served as the Chief Growth Officer for Guidehouse, where he was respon

    12/3/24 6:30:00 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    $PINC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Premier Inc.

    SC 13G - Premier, Inc. (0001577916) (Subject)

    10/31/24 11:55:01 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Premier Inc. (Amendment)

    SC 13G/A - Premier, Inc. (0001577916) (Subject)

    2/13/24 5:12:15 PM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Premier Inc. (Amendment)

    SC 13G/A - Premier, Inc. (0001577916) (Subject)

    1/23/24 11:52:26 AM ET
    $PINC
    Other Consumer Services
    Consumer Discretionary